ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,304.80
      2.37%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      74.06
      -0.35%
      Bitcoin
      63,876.55
      1.48%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Rallybio Holdings LLC (RLYB) Quote

      Rallybio Holdings LLC

      Rallybio Holdings LLC (RLYB)

      NASDAQ
      1.10
      0.00
      (0.00%)
      Closed September 20 4:00PM
      Delayed by 15 minutes
      1.10
      0.00
      (0.00%)
      After Hours: 7:50PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.10
      Bid
      1.10
      Ask
      1.25
      Volume
      52,153
      1.10 Day's Range 1.13
      1.09 52 Week Range 5.03
      Market Cap
      45.636M
      Previous Close
      1.10
      Open
      1.13
      Last Trade
      100
      @
      1.1
      (formt)
      Last Trade Time
      Financial Volume
      $ 58,311
      VWAP
      1.1181
      Average Volume (3m)
      156,125
      Shares Outstanding
      41,487,586
      Dividend Yield
      -
      PE Ratio
      -0.61
      Earnings Per Share (EPS)
      -1.8
      Revenue
      -
      Net Profit
      -74.56M

      About Rallybio Holdings LLC

      Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.rallybio.com.
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Rallybio Holdings LLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was $1.10. Over the last year, Rallybio shares have traded in a share price range of $ 1.09 to $ 5.03.

      Rallybio currently has 41,487,586 shares outstanding. The market capitalization of Rallybio is $45.64 million. Rallybio has a price to earnings ratio (PE ratio) of -0.61.

      Ask ADVFN Intelligence (AI)

      RLYB Latest News

      More News

      Form 8-K - Current report

      September 17 2024
      Edgar (US Regulatory)

      Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit

      Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, announced...

      September 10 2024
      Business Wire

      Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree

      Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, announced...

      September 09 2024
      Business Wire

      Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis

      – Study Demonstrates that RLYB212 Rapidly Clears HPA-1a Positive Platelets, an Essential Step in Preventing Alloimmunization and FNAIT – – Rallybio On Track to Initiate RLYB212 Phase 2 Dose...

      August 29 2024
      Business Wire

      Rallybio to Present at Upcoming Investor Conferences

      Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today...

      August 27 2024
      Business Wire

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates

      – On Track to Initiate RLYB212 Phase 2 Dose Confirmation Trial in Pregnant Women at Higher Risk of FNAIT in 4Q 2024 – – $88.6 Million in Cash, Cash Equivalents, and Marketable Securities as of...

      August 08 2024
      Business Wire

      Form 8-K - Current report

      July 23 2024
      Edgar (US Regulatory)

      Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

      Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today...

      July 09 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0104-0.9365994236311.11041.19071.1388331.10518549CS
      4-0.05-4.347826086961.151.251.09556801.13090853CS
      12-0.32-22.53521126761.421.541.091561251.28447832CS
      26-0.5-31.251.63.461.098640582.61591572CS
      52-3.68-76.98744769874.785.031.095158622.54017241CS
      156-11.75-91.43968871612.85211.092272354.05623758CS
      260-13.82-92.627345844514.9225.781.092257424.50163792CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GSIWGarden Stage Ltd
      $ 8.17
      (259.91%)
      		70.64M
      ZEOZeo Energy Corporation
      $ 2.5995
      (128.03%)
      		59.98M
      TBIOTelesis Bio Inc
      $ 2.9201
      (114.71%)
      		53.74M
      NCINeo Concept International Group Holdings Ltd
      $ 0.84
      (71.43%)
      		12.68M
      VEROVenus Concept Inc
      $ 0.8475
      (68.66%)
      		20.56M
      HAOHaoxi Health Technology Ltd
      $ 0.83
      (-72.33%)
      		8.28M
      PGNYProgyny Inc
      $ 16.465
      (-32.63%)
      		19.16M
      NUZENuZee Inc
      $ 0.6998
      (-32.06%)
      		14.06M
      RGFReal Good Food Company Inc
      $ 0.308
      (-28.37%)
      		363.05k
      ALGSAligos Therapeutics Inc
      $ 10.18
      (-28.11%)
      		875.5k
      NVDANVIDIA Corporation
      $ 117.87
      (3.97%)
      		293.54M
      SQQQProShares UltraPro Short QQQ
      $ 7.76
      (-7.62%)
      		222.56M
      HOLOMicroCloud Hologram Inc
      $ 0.2328
      (15.08%)
      		120.19M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.1034
      (13.75%)
      		105.03M
      TSLATesla Inc
      $ 243.92
      (7.36%)
      		102.7M

      RLYB Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      RLYB under $2
      👍️0
      Monksdream Monksdream 2 months ago
      RLYB
      👍️0
      Monksdream Monksdream 5 months ago
      RLYB under $2
      👍️0
      glenn1919 glenn1919 5 months ago
      RLYB.................................https://stockcharts.com/h-sc/ui?s=RLYB&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 5 months ago
      Early Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
      👍️0
      glenn1919 glenn1919 5 months ago
      RLYB............................https://stockcharts.com/h-sc/ui?s=RLYB&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 7 months ago
      RLYB under $2
      👍️0

      Your Recent History

      NASDAQ
      RLYB
      Rallybio
      Delayed Upgrade Clock